SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
30-Aug-17 7:03 PM View: | Hayes William B Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 17,447 | $35.00 | $610,645.00 | (100%) 17.45K to 0 | < 1% |
31-Aug-17 6:25 PM View: | Gill Harry R III SVP, Quality/Continuous Imprvt | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (other) | 105,800 | -- | -- | (25%) 417.97K to 312.17K | |
31-Aug-17 6:26 PM View: | Negron Francisco R. President, Drug Product Svcs | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 11,231 | -- | -- | (3%) 341.4K to 330.17K | |
31-Aug-17 6:26 PM View: | Lehmann Michael J. EVP, Global Sales and Mktng | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (other) | 191,772 | -- | -- | (33%) 576.49K to 384.72K | |
31-Aug-17 6:26 PM View: | Mullen James C Chief Executive Officer Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (other) | 906,858 | -- | -- | (25%) 3.62M to 2.71M | |
31-Aug-17 6:24 PM View: | Cottier Gilles President, Pharma Dev Svcs | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 70,141 | -- | -- | (100%) 70.14K to 0 | |
31-Aug-17 6:27 PM View: | Schneier Craig Eric EVP and Chief Talent Officer | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 48,755 | $35.00 | $1,706,420.00 | (100%) 48.76K to 0 | < 1% |
31-Aug-17 6:28 PM View: | Utiger Lukas President, Drug Substance Svcs | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) Duplicate | 373,754 | $35.00 | $13,081,400.00 | (100%) 373.75K to 0 | |
31-Aug-17 6:27 PM View: | Sherbet Eric General Counsel and Secretary | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (other) | 219,330 | -- | -- | (61%) 361.48K to 142.15K | |
30-Aug-17 8:32 AM View: | Koninklijke Dsm N.V. 10% Owner | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 48,697,300 | $35.00 | $1,704,409,984.00 | (100%) 48.7M to 0 | < 1% |
30-Aug-17 7:03 PM View: | Levy Paul S Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 62,000 | $35.00 | $2,170,000.00 | (100%) 62.0K to 0 | < 1% |
31-Aug-17 6:25 PM View: | Grant Stuart EVP and CFO | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (other) | 196,485 | -- | -- | (26%) 763.09K to 566.6K | |
30-Aug-17 7:04 PM View: | Tanda Stephan B. Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 4,659 | $35.00 | $163,065.00 | (100%) 4.66K to 0 | < 1% |
30-Aug-17 7:01 PM View: | Cogut Charles I Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 4,061 | $35.00 | $142,135.00 | (100%) 4.06K to 0 | < 1% |
31-Aug-17 6:27 PM View: | New Rebecca Holland EVP, Enterprise Operations | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 286,585 | $35.00 | $10,030,500.00 | (100%) 286.58K to 0 | |
31-Aug-17 6:25 PM View: | Gill Harry R III SVP, Quality/Continuous Imprvt | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 7,078 | -- | -- | (2%) 312.17K to 305.09K | |
31-Aug-17 6:26 PM View: | Negron Francisco R. President, Drug Product Svcs | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 330,169 | $35.00 | $11,555,900.00 | (100%) 330.17K to 0 | |
31-Aug-17 6:26 PM View: | Lehmann Michael J. EVP, Global Sales and Mktng | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 10,966 | -- | -- | (3%) 384.72K to 373.75K | |
31-Aug-17 6:26 PM View: | Mullen James C Chief Executive Officer Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 93,432 | -- | -- | (3%) 2.71M to 2.62M | |
31-Aug-17 6:28 PM View: | Utiger Lukas President, Drug Substance Svcs | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (other) | 191,772 | -- | -- | (33%) 577.95K to 386.17K | |
30-Aug-17 7:02 PM View: | Eykerman Philip Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 28,000 | $35.00 | $980,000.00 | (100%) 28.0K to 0 | < 1% |
31-Aug-17 6:27 PM View: | Sherbet Eric General Counsel and Secretary | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 12,552 | -- | -- | (9%) 142.15K to 129.59K | |
30-Aug-17 7:03 PM View: | Jll Associates G.P. V (path... 10% Owner | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 62,466,800 | $35.00 | $2,186,340,096.00 | (100%) 62.47M to 0 | < 1% |
30-Aug-17 7:04 PM View: | Pisano Gary P. Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 17,447 | $35.00 | $610,645.00 | (100%) 17.45K to 0 | < 1% |
31-Aug-17 6:25 PM View: | Grant Stuart EVP and CFO | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 566,603 | $35.00 | $19,831,100.00 | (100%) 566.6K to 0 | |
31-Aug-17 6:28 PM View: | Torres Raul Cardona SVP, Quality | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 13,112 | -- | -- | (100%) 13.11K to 0 | |
31-Aug-17 6:27 PM View: | New Rebecca Holland EVP, Enterprise Operations | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (other) | 161,543 | -- | -- | (35%) 458.43K to 296.89K | |
31-Aug-17 6:26 PM View: | Negron Francisco R. President, Drug Product Svcs | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (other) | 261,322 | -- | -- | (43%) 602.72K to 341.4K | |
31-Aug-17 6:25 PM View: | Gill Harry R III SVP, Quality/Continuous Imprvt | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 305,094 | $35.00 | $10,678,300.00 | (100%) 305.09K to 0 | |
30-Aug-17 7:02 PM View: | Hasler Hans Peter Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 16,864 | $35.00 | $590,240.00 | (100%) 16.86K to 0 | < 1% |
31-Aug-17 6:26 PM View: | Lehmann Michael J. EVP, Global Sales and Mktng | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 373,754 | $35.00 | $13,081,400.00 | (100%) 373.75K to 0 | |
31-Aug-17 6:26 PM View: | Mullen James C Chief Executive Officer Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 2,615,090 | $35.00 | $91,528,096.00 | (100%) 2.62M to 0 | |
30-Aug-17 7:02 PM View: | Daley Pamela Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 67,120 | $35.00 | $2,349,200.00 | (100%) 67.12K to 0 | < 1% |
31-Aug-17 6:28 PM View: | Utiger Lukas President, Drug Substance Svcs | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 12,420 | -- | -- | (3%) 386.17K to 373.75K | |
31-Aug-17 6:27 PM View: | Sherbet Eric General Counsel and Secretary | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 129,595 | $35.00 | $4,535,820.00 | (100%) 129.59K to 0 | |
31-Aug-17 6:30 PM View: | Lagarde Michel President | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 245,939 | -- | -- | (100%) 245.94K to 0 | |
30-Aug-17 7:04 PM View: | McMullen Jeffrey P Director | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 27,447 | $35.00 | $960,645.00 | (100%) 27.45K to 0 | < 1% |
31-Aug-17 6:28 PM View: | Wilson Dean Frederick Chief Accounting Officer | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 126,518 | -- | -- | (100%) 126.52K to 0 | |
31-Aug-17 6:27 PM View: | New Rebecca Holland EVP, Enterprise Operations | Patheon N.V. (PTHN) | 29-Aug-17 | Disposition (change in control) | 10,306 | -- | -- | (3%) 296.89K to 286.58K | |
24-Jul-17 12:00 PM View: | Torres Raul Cardona SVP, Quality | Patheon N.V. (PTHN) | 20-Jul-17 | Payment of Exercise | 786 | $34.90 | $27,431.40 | (6%) 13.9K to 13.11K | < 1% |
24-Jul-17 12:06 PM View: | Lagarde Michel President | Patheon N.V. (PTHN) | 20-Jul-17 | Payment of Exercise | 34,625 | $34.90 | $1,208,410.00 | (12%) 280.56K to 245.94K | < 1% |
24-Jul-17 12:04 PM View: | Schneier Craig Eric Executive Vice President & CTO | Patheon N.V. (PTHN) | 20-Jul-17 | Payment of Exercise | 5,914 | $34.90 | $206,399.00 | (11%) 54.67K to 48.76K | < 1% |
27-Mar-17 3:20 PM View: | Lagarde Michel President | Patheon N.V. (PTHN) | 23-Mar-17 | Grant | 42,469 | -- | -- | 18% 238.09K to 280.56K | |
27-Mar-17 3:14 PM View: | New Rebecca Holland EVP, Enterprise Operations | Patheon N.V. (PTHN) | 23-Mar-17 | Grant | 10,306 | -- | -- | 6% 161.54K to 171.85K | |
27-Mar-17 3:09 PM View: | Gill Harry R III SVP, Quality & Improvement | Patheon N.V. (PTHN) | 23-Mar-17 | Grant | 7,078 | -- | -- | 7% 105.8K to 112.88K | |
27-Mar-17 3:17 PM View: | Negron Francisco R. President, Drug Product Svcs | Patheon N.V. (PTHN) | 23-Mar-17 | Grant | 11,231 | -- | -- | 4% 261.32K to 272.55K | |
27-Mar-17 1:24 PM View: | Daley Pamela Director | Patheon N.V. (PTHN) | 23-Mar-17 | Grant | 7,102 | -- | -- | 63% 11.22K to 18.32K | |
27-Mar-17 2:01 PM View: | McMullen Jeffrey P Director | Patheon N.V. (PTHN) | 23-Mar-17 | Grant | 6,229 | -- | -- | 56% 11.22K to 17.45K | |
27-Mar-17 2:50 PM View: | Wilson Dean Frederick Chief Accounting Officer | Patheon N.V. (PTHN) | 23-Mar-17 | Grant | 8,519 | -- | -- | 7% 118.0K to 126.52K | |
27-Mar-17 2:47 PM View: | Pisano Gary P. Director | Patheon N.V. (PTHN) | 23-Mar-17 | Grant | 6,229 | -- | -- | 56% 11.22K to 17.45K |